Impact of an Antimicrobial Stewardship Pharmacist's Intervention on Blood Culture-positive Patients
Yasuhiro SASAKI1)6), Misato AMANO1)6), Ayumi KANAMARU2)6), Akiko YAMAKUCHI3)6), Hirobumi TAKAYASU4)6) and Masataka YANO5)6) 1)Department of Pharmacy, Tama-Nanbu Chiiki Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation, 2)Department of Nursing, Tama-Nanbu Chiiki Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation, 3)Department of Microbiological Laboratory, Tama-Nanbu Chiiki Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation, 4)Department of Pediatrics, Tama-Nanbu Chiiki Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation, 5)Department of Urology, Tama-Nanbu Chiiki Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation, 6)Antimicrobial Stewardship Team, Tama-Nanbu Chiiki Hospital, Tokyo Metropolitan Health and Medical Treatment Corporation
In March 2018, an antimicrobial stewardship (AS) team commenced an active intervention in patients with bacteremia at the Tama-Nanbu Chiiki Hospital, Japan. An AS pharmacist audited and reviewed the prescription of antimicrobial agents in patient with bacteremia and suggested empirical and definitive changes to the antimicrobials. A total of 247 patients were evaluated, which resulted in 102 interventions, with 88% acceptance rate. The rate of appropriate de-escalation rose from 55% to 79% (p < 0.05). Although the total consumption of antimicrobial agents did not markedly change the observation period, the use of broad-spectrum antibiotics such as tazobactam/piperacillin was significantly decreased. It was concluded that the activities of the AS team are important as they lead to proper selection of antimicrobial drug therapy.
Key words:antimicrobial stewardship program, bacteremia, de-escalation
e-mail:
yasuhiro_sasaki1@tokyo-hmt.jp
Received: November 8, 2019 Accepted: April 20, 2020
35 (4):157─162,2020
|